Pharming Group N.V. (AMS:PHARM)

Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.94	61.74	207.34	191.92	205.16
Short-Term Investments	112.95	151.68	-	-	-
Cash & Short-Term Investments	167.89	213.42	207.34	191.92	205.16
Cash Growth	-21.33%	2.93%	8.03%	-6.45%	175.94%
Accounts Receivable	41.53	35.41	20.96	18.08	23.51
Other Receivables	8.64	7.21	4.37	9.52	8.37
Receivables	50.17	42.62	25.33	27.59	31.88
Inventory	55.72	56.76	42.33	27.31	21.16
Prepaid Expenses	4.65	3.54	2.29	2.39	4.02
Restricted Cash	-	-	0.21	0.23	1
Total Current Assets	278.44	316.34	277.5	249.44	263.21
Property, Plant & Equipment	24.13	33.47	39.15	33.17	21.65
Long-Term Investments	4.23	10.4	9.73	8.65	7.12
Other Intangible Assets	61.04	71.27	74.87	83.57	88.63
Long-Term Deferred Tax Assets	30.54	29.76	22.97	21.22	31.88
Long-Term Deferred Charges	-	-	0.25	0.27	5.46
Other Long-Term Assets	1.6	1.62	1.33	1.01	0.51
Total Assets	399.99	462.85	425.8	397.32	418.45
Accounts Payable	10.1	16.02	8.75	7.6	13.47
Accrued Expenses	53.22	50.27	43.61	33.34	33.4
Current Portion of Long-Term Debt	4.25	1.82	1.77	1.88	2.04
Current Portion of Leases	2.95	3.62	3.47	2.42	1.96
Current Income Taxes Payable	3.28	6.23	2.1	1.51	0.62
Other Current Liabilities	-	-	-	0.03	25.36
Total Current Liabilities	73.8	77.97	59.7	46.77	76.85
Long-Term Debt	78.15	136.6	131.62	139.01	149.73
Long-Term Leases	26.97	29.51	29.84	18.46	8.23
Other Long-Term Liabilities	-	-	-	0.17	0.21
Total Liabilities	178.92	244.07	221.16	204.4	235.02
Common Stock	7.77	7.67	7.51	7.43	7.31
Additional Paid-In Capital	488.99	478.43	462.3	455.25	447.13
Retained Earnings	-287.92	-265.5	-265.17	-269.77	-271.01
Comprehensive Income & Other	12.23	-1.82	-	-	-
Shareholders' Equity	221.06	218.78	204.64	192.92	183.44
Total Liabilities & Equity	399.99	462.85	425.8	397.32	418.45
Total Debt	112.31	171.55	166.69	161.76	161.96
Net Cash (Debt)	55.58	41.88	40.65	30.16	43.2
Net Cash Growth	32.72%	3.03%	34.76%	-30.18%	167.52%
Net Cash Per Share	0.08	0.06	0.06	0.04	0.06
Filing Date Shares Outstanding	683.93	673.44	656.35	648.75	641.29
Total Common Shares Outstanding	680.31	671.07	656.35	648.75	638.82
Working Capital	204.64	238.37	217.8	202.67	186.36
Book Value Per Share	0.32	0.33	0.31	0.30	0.29
Tangible Book Value	160.02	147.51	129.77	109.35	94.81
Tangible Book Value Per Share	0.24	0.22	0.20	0.17	0.15
Land	-	-	-	0.03	0.03
Machinery	9.3	9.66	8.28	14.84	6.59
Construction In Progress	0.15	0.18	0.01	0.62	2.87
Leasehold Improvements	5.43	5.55	5.28	5.71	2.48

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.